Cytokine PharmaSciences Report issue

For profit Phase 2
Founded: King of Prussia PA United States (1999)
Status: Acquired by Ferring (2011)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (8)

Key: Cytokine PharmaSciences (0) Acquired (8)

aeg33773 (1 trial)

aeg35156 (7 trials)

cholestyramine (questran) (1 trial)

decitabine (dacogen) (1 trial)

genistein (1 trial)

isoquercetin (1 trial)

sorafenib (nexavar) (1 trial)

xiap antisense (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 12
  • # of Trial APIs: 8